Trial Profile
Phase 1 Study of B-cell Depletion With Rituximab on Oral, Ocular and General Disease Manifestations in Patients With Primary Sjogren's Syndrome.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Sjogren's syndrome
- Focus Therapeutic Use
- 22 Jan 2011 New trial record